Tenpoint Therapeutics
UK - LondonBiotechnology
Focus: Tenpoint Therapeutics is a UK-based public biotechnology company focused on vision-restoring therapies in ophthalmology, with active development in presbyopia treatments. The company is in early commercialization phase with a lean R&D footprint.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
6-2 this month
Stable — net -2 jobs in 30d
3 added, 5 removed. Backfill posture.
Should You Work at Tenpoint Therapeutics?
AI assessmentTenpoint is a high-risk, high-reward specialist play suitable for commercial and sales professionals willing to bet on a single-indication strategy, but limited for R&D and clinical careers.
Why Work Here
- Specialized focus on a high-unmet-need ophthalmology segment (presbyopia) with manufacturing partnerships already in place to de-risk launch
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Tenpoint Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.